Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Completed · Phase 4 · Has a placebo group

Conditions studied: Heart Failure, Congestive, Cardiomyopathy

In brief

The purpose of this study is to determine if an 8hr infusion of nesiritide in the emergency department in the Acutely decompensated heart failure patients will decrease 30 day recidivism.

Key facts

Study ID
NCT00559338
Run by
University of Texas Southwestern Medical Center
People needed
104
Starts
2003-12-01
Expected to finish
2005-04-01
Last updated by the study team
2007-11-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.